Epigenetic machinery hijacked by some breast cancer tumors to evade drug therapy

[News]

A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, including permanent DNA modifications in the patient's tumor, once again allowing tumor growth, according to an international team headed by the University of Pittsburgh Cancer Institute (UPCI).

More... (http://www.medicalnewstoday.com/releases/274649.php)